Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 13.25
-0.25 (-1.85%)
Oct 31, 2025, 2:00 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 58.86 million as of October 31, 2025. Its market cap has increased by 220.42% in one year.
Market Cap
58.86M
Enterprise Value
56.18M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.25
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 58.86M, a decrease of -47.85%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 58.86M | 65.55% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |